This is a StreetInsider.com Premium Only Page

(OYST) – SEC Filings

Jan 13, 2023 05:11 PM Form 15-12G Oyster Point Pharma,

Jan 13, 2023 05:06 PM Form 8-K/A Oyster Point Pharma, For: Jan 03

Jan 13, 2023 04:10 PM Form SC 13D/A Oyster Point Pharma, Filed by: Versant Venture Capital VI, L.P.

Jan 9, 2023 04:33 PM Form SC 13D/A Oyster Point Pharma, Filed by: New Enterprise Associates 14, L.P.

Jan 6, 2023 06:04 AM Form EFFECT Oyster Point Pharma,

Jan 5, 2023 04:33 PM Form SC 13D/A Oyster Point Pharma, Filed by: InvOpps IV US, L.P.

Jan 5, 2023 04:31 PM Form 4 Oyster Point Pharma, For: Jan 03 Filed by: InvOpps IV, L.P.

Jan 4, 2023 06:12 PM Form 4 Oyster Point Pharma, For: Jan 03 Filed by: Versant Ventures VI GP-GP, LLC

Jan 4, 2023 05:17 PM Form 4 Oyster Point Pharma, For: Jan 03 Filed by: Behbahani Ali

Jan 4, 2023 05:16 PM Form 4 Oyster Point Pharma, For: Jan 03 Filed by: NEA 14 GP, LTD

Jan 4, 2023 05:10 PM Form 4 Oyster Point Pharma, For: Jan 03 Filed by: WEISNER AIMEE S

Jan 4, 2023 05:09 PM Form 4 Oyster Point Pharma, For: Jan 03 Filed by: Tsai Benjamin

Jan 4, 2023 05:08 PM Form 4 Oyster Point Pharma, For: Jan 03 Filed by: Ozawa Clare

Jan 4, 2023 05:08 PM Form 4 Oyster Point Pharma, For: Jan 03 Filed by: Santel Donald J

Jan 4, 2023 05:06 PM Form 4 Oyster Point Pharma, For: Jan 03 Filed by: Murray Mark Anthony

Jan 4, 2023 05:06 PM Form 4 Oyster Point Pharma, For: Jan 29 Filed by: Nau Jeffrey

Jan 4, 2023 05:04 PM Form 4 Oyster Point Pharma, For: Jan 29 Filed by: Lochner Daniel

Jan 4, 2023 05:03 PM Form 4 Oyster Point Pharma, For: Jan 03 Filed by: Eliades George Christopher

Jan 4, 2023 05:02 PM Form 4 Oyster Point Pharma, For: Jan 03 Filed by: ATIEH MICHAEL G

Jan 3, 2023 09:52 AM Form 25-NSE Oyster Point Pharma, Filed by: Nasdaq Stock Market LLC

Jan 3, 2023 09:27 AM Form S-8 POS Oyster Point Pharma,

Jan 3, 2023 09:26 AM Form S-8 POS Oyster Point Pharma,

Jan 3, 2023 09:24 AM Form S-8 POS Oyster Point Pharma,

Jan 3, 2023 09:23 AM Form S-8 POS Oyster Point Pharma,

Jan 3, 2023 09:19 AM Form POS AM Oyster Point Pharma,

Jan 3, 2023 09:12 AM Form 8-K Oyster Point Pharma, For: Jan 03

Jan 3, 2023 09:10 AM Form SC 14D9/A Oyster Point Pharma, Filed by: Oyster Point Pharma, Inc.

Jan 3, 2023 09:07 AM Form SC TO-T/A Oyster Point Pharma, Filed by: Viatris Inc

Dec 23, 2022 06:31 AM Form SC 14D9/A Oyster Point Pharma, Filed by: Oyster Point Pharma, Inc.

Dec 22, 2022 05:16 PM Form SC 14D9 Oyster Point Pharma, Filed by: Oyster Point Pharma, Inc.

Dec 21, 2022 06:04 AM Form SC 13D/A Oyster Point Pharma, Filed by: InvOpps IV US, L.P.

Dec 9, 2022 07:01 AM Form SC 14D9/A Oyster Point Pharma, Filed by: Oyster Point Pharma, Inc.

Dec 9, 2022 07:01 AM Form SC TO-T/A Oyster Point Pharma, Filed by: Viatris Inc

Dec 6, 2022 07:06 PM Form 4/A Oyster Point Pharma, For: Dec 01 Filed by: Nau Jeffrey

Dec 6, 2022 08:51 AM Form 4 Oyster Point Pharma, For: Dec 01 Filed by: Lochner Daniel

Dec 5, 2022 05:36 PM Form 4 Oyster Point Pharma, For: Dec 01 Filed by: Nau Jeffrey

Dec 1, 2022 07:39 AM Form SC 14D9 Oyster Point Pharma, Filed by: Oyster Point Pharma, Inc.

Dec 1, 2022 06:11 AM Form SC TO-T Oyster Point Pharma, Filed by: Viatris Inc

Nov 21, 2022 01:29 PM Form SC 13D/A Oyster Point Pharma, Filed by: New Enterprise Associates 14, L.P.

Nov 16, 2022 04:25 PM Form SC14D9C Oyster Point Pharma, Filed by: Oyster Point Pharma, Inc.

Nov 14, 2022 08:10 AM Form SC TO-C Oyster Point Pharma, Filed by: Viatris Inc

Nov 10, 2022 04:14 PM Form 10-Q Oyster Point Pharma, For: Sep 30

Nov 10, 2022 04:11 PM Form 8-K Oyster Point Pharma, For: Nov 10

Nov 8, 2022 05:23 PM Form SC14D9C Oyster Point Pharma, Filed by: Oyster Point Pharma, Inc.

Nov 8, 2022 05:20 PM Form 8-K Oyster Point Pharma, For: Nov 07

Nov 8, 2022 06:07 AM Form SC TO-C Oyster Point Pharma, Filed by: Viatris Inc

Nov 7, 2022 05:27 PM Form SC TO-C Oyster Point Pharma, Filed by: Viatris Inc

Nov 7, 2022 05:23 PM Form SC14D9C Oyster Point Pharma, Filed by: Oyster Point Pharma, Inc.

Nov 7, 2022 10:01 AM Form SC14D9C Oyster Point Pharma, Filed by: Oyster Point Pharma, Inc.

Nov 7, 2022 08:15 AM Form 8-K Oyster Point Pharma, For: Nov 07